Investment Firm
Overview
Solace Therapeutics develops and commercializes non-surgical office-based treatments for common bladder disorders.
Apr 01, 2020
Series B
Highlights
Location
Social
Investor Lead
Participant Investors
2
Investor Name |
---|
Jennifer Fried |
Portfolia |
Solace Therapeutics raised an undisclosed amount on 2020-04-01 in Series B
Solace Therapeutics develops and commercializes non-surgical office-based treatments for common bladder disorders.
Company Funding History
5
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Sep 06, 2016 | Venture Round - Solace Therapeutics | - | 13.0M | |
Aug 09, 2006 | Series B - Solace Therapeutics | 2 | - | 3.0M |
Jun 01, 2014 | Venture Round - Solace Therapeutics | 1 | - | 13.0M |
Mar 28, 2012 | Venture Round - Solace Therapeutics | 3 | - | 7.0M |
Recent Activity
There is no recent news or activity for this profile.